Innovation versus Financialization in the US Pharmaceutical Industry - Oner Tulum, William Lazonick

Prodává: Dobrovský
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends…
Další informace
594 Kč
Skladem
Koupit

Popis produktu

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'

Podobné produkty